JUBILANT PHARMOVA LTD

JUBLPHARMA NSE
JUBLPHARMA
JUBILANT PHARMOVA LTD NSE
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

JUBLPHARMA Stock Chart

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Other
Jubilant Pharmova Ltd. engages in the provision of basic organic chemicals. It operates through the following segments: Pharmaceuticals, Contract Research & Development Services and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the maintenance and establishment of market positions in business. The Contract Research & Development Services segment engages in contract manufacturing of sterile injectable and non-sterile products and its active pharmaceutical ingredients (APIs) businesses. The Proprietary Novel Drugs segment develops breakthrough therapies in the area of oncology and auto-immune disorders. The company was founded on June 21, 1978 and is headquartered in Noida, India.

Breaking news